Scared to Publish, New Documents Reveal Boehringer Feared Reaction to Pradaxa Study
From Ring of Fire:
Boehringer Ingelheim, the manufacturer of the popular blood thinning agent Pradaxa, has been embroiled in litigation over the blood thinner for years. Recently filed discover documents have revealed that the company made an internal effort to cover up the potentially life threatening dangers associated with its product and the need for additional testing of those that had been administered the drug.
The emails expose that the company had an internal dialogue where employees expressed concerns about the aggregating effect of Pradaxa in a patients blood and the need to continue monitoring a patient’s levels to try and prevent cardiac trauma or fatal bleeding.
At the time, the company was pushing its drug toward regulatory approval and worried the publication of a new study would complicate the talks and cast aspersion on Pradaxa.
You can read the full article here at Ring of Fire.
= new reply since forum marked as read
